US OptionsDetailed Quotes
OCGN250117P3500
- 0.00
- 0.000.00%
15min DelayClose Dec 27 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest3.50Strike Price0.00Turnover672.45%IV-314.20%PremiumJan 17, 2025Expiry Date2.65Intrinsic Value100Multiplier20DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.5437Delta0.2989Gamma0.29Leverage Ratio-0.0130Theta-0.0013Rho-0.16Eff Leverage0.0008Vega
Ocugen Stock Discussion
Sign in to post a comment
$Ocugen (OCGN.US)$ bad performance, sell it first
1
$Ocugen (OCGN.US)$ yes i will hold this for long term
Others consist of some losers I will die holding. $La Rosa Holdings (LRHC.US)$ $Stem Inc (STEM.US)$ $Ocugen (OCGN.US)$ $XTI Aerospace (XTIA.US)$
1
$Ocugen (OCGN.US)$ good news out , les make alittle move up
$Ocugen (OCGN.US)$ Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
GlobeNewswire· 5 mins ago
OCU410 has a very favorable safety and tolerability profileNo serious adverse events related to the study drug have been reported, such as exudation, infectious endophthalmitis, intraocular Inflammation, anterior ischemic optic neuropathy, or vasculitis
GlobeNewswire· 5 mins ago
OCU410 has a very favorable safety and tolerability profileNo serious adverse events related to the study drug have been reported, such as exudation, infectious endophthalmitis, intraocular Inflammation, anterior ischemic optic neuropathy, or vasculitis
$Ocugen (OCGN.US)$ just buy a bit. very few chances to get rich
$Ocugen (OCGN.US)$
Grabbed a few at .88. It usually hovers around $1-2, a little upside
Grabbed a few at .88. It usually hovers around $1-2, a little upside
$Ocugen (OCGN.US)$ i will buy when it drops more
$Ocugen (OCGN.US)$ Reuters· 3 mins ago
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
2
No comment yet
104981603 : It shouldn't have reached the full decline point of around 0.55 for the big M head yet. The next support could be around 0.66, there might be some rebound.